                         SEQUENCE LISTING

<110>  Universitt Heidelberg
 
<120>  Method of making oral dosage forms

<130>  UH0002P-EP

<160>  9     

<170>  PatentIn version 3.5

<210>  1
<211>  16
<212>  PRT
<213>  Drosophila melanogaster

<400>  1

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


<210>  2
<211>  16
<212>  PRT
<213>  Human immunodeficiency virus type 1

<400>  2

Cys Gly Arg Lys Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Cys 
1               5                   10                  15      


<210>  3
<211>  27
<212>  PRT
<213>  Artificial sequence

<220>
<223>  artificially designed cell penetrating peptide

<400>  3

Gly Ala Leu Phe Leu Gly Phe Leu Gly Ala Ala Gly Ser Thr Met Gly 
1               5                   10                  15      


Ala Trp Ser Gln Pro Lys Ser Lys Arg Lys Val 
            20                  25          


<210>  4
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  artificially designed cell penetrating peptide

<400>  4

Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   


<210>  5
<211>  18
<212>  PRT
<213>  Mus musculus


<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  K-amide

<400>  5

Leu Leu Ile Ile Leu Arg Arg Arg Ile Arg Lys Gln Ala His Ala His 
1               5                   10                  15      


Ser Lys 
        


<210>  6
<211>  28
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  L-amide

<400>  6

Gly Trp Thr Leu Asn Ser Ala Gly Tyr Leu Leu Gly Lys Ile Asn Leu 
1               5                   10                  15      


Lys Ala Leu Ala Ala Leu Ala Lys Ile Ser Ile Leu 
            20                  25              


<210>  7
<211>  27
<212>  PRT
<213>  Human immunodeficiency virus

<400>  7

Gly Ala Leu Phe Leu Gly Phe Leu Gly Ala Ala Gly Ser Thr Met Gly 
1               5                   10                  15      


Ala Trp Ser Gln Pro Lys Ser Lys Arg Lys Val 
            20                  25          


<210>  8
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  artificially designed cell penetrating peptide

<400>  8

Arg Arg Arg Arg Arg Arg Arg Arg Arg Cys
1               5                   10


<210>  9
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  artificially designed cell penetrating peptide

<400>  9

Arg Arg Arg Arg Arg Arg Arg Arg Arg Lys
1               5                   10
